IP Library › Granted Patent US 11,419,801
Granted Patent B2
US 11,419,801 · App. 16/641,709 · Granted Aug 23, 2022

Personal care composition

Inventors: Chenliang Guo (Shanghai, CN); Nan Huang (Shanghai, CN); Sheila Alves Rocha (Bogota, NJ)
Assignee: CONOPCO, INC.
A61K8/361A61K8/347A61K8/37A61K8/42A61K8/676A61K8/9778A61Q5/00A61Q11/00A61Q19/08A61K2800/59A61K2800/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,419,801
App. No.
16/641,709
Granted
Aug 23, 2022
Kind
B2
Abstract

The invention relates to a personal care composition, more particularly to a composition for application to a topical surface that prevents or reduces inflammation. The composition could be delivered in the form of a skin, scalp, hair or oral care product, more particularly a skin care product. The benefit is delivered via a combination of a polyunsaturated fatty acid (PUFA) or ester thereof selected from docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), DHA-ethyl ester, EPA-ethyl ester, DHA-triglyceride, EPA-triglyceride, dihomogamma-Linolenic Acid (DGLA), DGLA-ethyl ester, DGLA-triglyceride or combinations thereof and a 4-substituted resorcinol compound, wherein the mole ratio of the PUFA or ester thereof to the 4-substituted resorcinol compound is 5:1 to 1:5.

Claims (13)

1. A personal care composition comprising:

(i) 0.01 to 10% of docosahexaenoic acid (DHA) by weight of the personal care composition;

(ii) 4-hexyl resorcinol and,

(iii) a cosmetically acceptable base,

wherein the mole ratio of the docosahexaenoic acid (DHA) to the 4-hexyl resorcinol compound is 5:1 to 1:5.

2. The composition as claimed in claim 1 , comprising 0.01 to 5% docosahexaenoic acid (DHA) thereof by weight of the composition.

3. The composition as claimed in claim 1 , comprising 0.01 to 10% 4-hexyl resorcinol compound by weight of the composition.

4. The composition as claimed in claim 1 , wherein the cosmetically acceptable base comprises water, oil, surfactant, an emulsifying agent, a gelling agent or combinations thereof.

5. The composition as claimed in claim 1 , wherein said composition is in the form of an oral care, or a skin, scalp or hair care product.

6. A non-therapeutic method of reducing or preventing inflammation on a topical surface of a human or animal body comprising the step of applying the composition as claimed in claim 1 on to the surface.

7. The non-therapeutic method as claimed in claim 6 wherein the composition further comprises niacinamide.

8. The non-therapeutic method as claimed in claim 6 wherein the composition further comprises sunscreen.

9. The non-therapeutic method, as claimed in claim 6 wherein the composition further comprises green tea extract, ascorbic acid or both.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2020
From: GUO, CHENLIANG; HUANG, NAN; ROCHA, SHEILA ALVES
To: CONOPCO, INC., D/B/A UNILEVER
Reel/Frame 051945/0941 →
Priority Claims (2)
WO PCT/CN2017/099618 · Aug 30, 2017 · international
EP 17191915 · Sep 19, 2017 · regional
Continuity (1)
Related Publication 20200360252A1 · Nov 19, 2020